Genomic Health and the Oncotype DX Test

The addressable market in the U.S. is 120 million Americans, age 45 to 85. 60 million Americans in that group are not up to date with screening. So this thing really has grown probably beyond your wildest dreams when you took this job almost 15 years ago. But you still have a long way to go.